Related Experiment Video
Updated: Jun 6, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Concordance study of 3 direct-to-consumer genetic-testing services
Kenta Imai1, Larry J Kricka, Paolo Fortina
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Direct-to-consumer genetic testing shows high SNP data accuracy but varying disease risk assignments. Differences in SNPs and reference populations impact risk results, highlighting the need for ethnicity-matched data.
Area of Science:
- Genetics
- Bioinformatics
- Consumer Health
Background:
- Direct-to-consumer (DTC) genetic testing services offer ancestry and wellness evaluations.
- Large-scale single-nucleotide polymorphism (SNP) testing may contain errors, potentially leading to misclassified health risks.
- Evaluating DTC genetic testing accuracy and disease risk reporting is crucial for consumer understanding.
Purpose of the Study:
- To compare the accuracy and disease risk reporting of different direct-to-consumer (DTC) genetic testing services.
- To assess the concordance of SNP data and the variability in disease risk assignments across multiple testing platforms.
- To identify factors contributing to discrepancies in genetic risk assessment.
Main Methods:
- Comparative analysis of results from three DTC genetic testing services (23andMe, deCODEme, Navigenics) and one genomics analysis service (Expression Analysis).
- Evaluation of single-nucleotide polymorphism (SNP) data concordance across different genotyping platforms (DNA microarray, TaqMan® analysis).
- Assessment of variations in relative disease risk calculations, considering different SNPs and reference populations.
Main Results:
- High concordance rates (>99.6%) were observed for single-nucleotide polymorphism (SNP) data across the evaluated services.
- Significant differences were found in the relative disease risks assigned by DTC services for the same conditions.
- Variations in risk assignment are attributed to the use of different SNPs and reference populations in the analyses.
Conclusions:
- Excellent concordance exists for SNP analyses between different companies and platforms.
- Disparities in disease risk data arise from variations in SNPs utilized and reference population data.
- Further research is needed on the utility of DTC genetic information and the importance of ethnicity-specific risk data.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genomics
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Test Cross

